Skip to content
Search

Latest Stories

REALITY CHECK: Adapting your pharmacy to thrive in a post pandemic world

Gary Paragpuri says the new challenge for contractors will be to find novel ways of drawing in customers across different age groups, especially those that are more willing to move online…

Six months on from the two confirmed cases in York that marked the arrival of Covid-19 to the UK at the end of January, little has changed in terms of the threat presented by the virus.


There are promising signs of breakthroughs in treatments, with remdesivir appearing to shorten recovery time and evidence suggesting that dexamethasone cuts the risk of death by a third for patients on ventilators.

In parallel, huge efforts are being poured into the task of finding a vaccine and, at the time of writing, seven candidate drugs have accelerated their way through to phase 3 clinical trials.

As yet, however, no silver bullet has been found. And in discussing the promise of finding a vaccine with the BBC, Sir Jeremy Farrar, director of the Wellcome Trust, provided a reminder that first-generation vaccines would not solve everything, and that much would still rely on behavioural change.

Unintended consequences

Sir Jeremy’s comments largely relate to the enforced type of behavioural change, such as the wearing of masks in certain public spaces, the application of social distancing rules, and the need to self-isolate and get tested if there is concern that symptoms are present.

More difficult to predict are the unenforced behavioural changes among the UK population – the shifts in attitude, perception and opinion that trigger new thoughts, feelings and actions. For example, data released by Rightmove shows that inquiries about buying a home in a village jumped by 126 per cent in June and July across the UK compared with the same period in 2019.

Such trends hint at the fact that remote working is set to be a long-term trend for large proportions of the UK workforce beyond this year’s short-term blip. Indeed, research from US bank Morgan Stanley has shown that employees in the UK have been particularly reticent to return to the office, with just 34 per cent of white-collar employees having gone back to work compared with 83 per cent of office staff in France and 76 per cent in Italy.

Understandably, consumers aren’t rushing back to our high streets either. Footfall data from Springboard shows that while the general trend is on the up, overall numbers in July were almost 40 per cent below the same level a year ago.

Avoiding unnecessary contact

Put simply, people are content to stay at home wherever possible to avoid being in close contact with others and minimise their risk of infection. In this context, e-commerce has become an incredibly attractive proposition to the extent that eMarketer predicts the pandemic will cause overall spending online to rise 8.8 per cent above its pre-pandemic forecast level – or an additional £8.23bn of revenues.

Consumer willingness to move online is also seen in parts of the UK pharmacy sector with internet pharmacies such as Pharmacy2U and Echo, the online service from Lloydspharmacy, showing growth in EPS nominations and e-commerce, along with the digital arms of Well and Boots.

According to Statista, making a purchase from an online pharmacy is most common among individuals aged 35 to 44 – the core demographic of busy working parents. It is lowest among those aged 65 or older – an important and growing demographic for all pharmacies.

Pharmacy owners, therefore, have a series of challenges to address across the breadth of their customer base, all of whom appear to be seeking ways of minimising contact with others as far as practically possible.

For younger and middle-aged patients comfortable with online purchasing, there is the need to introduce greater levels of convenience. For older patients, many of whom will be on repeats, there is the need to provide a physical experience that continues to support social distancing.

Flexible options

At Hub and Spoke Innovations, our customers tell us they are seeing these behavioural shifts play out in subtle ways thanks to the 24/7 access provided by the Pharmaself24. There has been a rise in collections in the early hours of the morning as well as a rise in collections in the evening and later at night, whether by commuters who are now back in the office or by older patients who don’t just want to avoid queuing in-store but want to limit opportunities to come into contact with others entirely.

Perhaps when a vaccine arrives, these habits will change again, but given that they are unenforced choices, it’s also possible evidence of a more fundamental shift in behaviour.

Community pharmacy has shown a remarkable ability to adapt time and again as changes – whether driven by markets, governments or consumers – have presented new challenges. It now feels like we’re at that point again, so how will your pharmacy adapt?

Gary Paragpuri is the CEO of Hub and Spoke Innovations.

More For You

Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less